CoChat

Human CD1c+ DCs are critical cellular mediators of immune responses induced by immunogenic cell death

Open access
Di Blasio, Stefania, Wortel, Inge M. N., van Bladel, Diede A. G., de Vries, Laura E., Duiveman-de Boer, Tjitske, Worah, Kuntal, de Haas, Nienke, Buschow, Sonja I., de Vries, I. Jolanda M., Figdor, Carl G., Hato, Stanleyson V. · 2016 · OncoImmunology
Cited by 105

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Chemotherapeutics, including the platinum compounds oxaliplatin (OXP) and cisplatin (CDDP), are standard care of treatment for cancer. Although chemotherapy has long been considered immunosuppressive, evidence now suggests that certain cytotoxic agents can efficiently stimulate antitumor responses, through the induction of a form of apoptosis, called immunogenic cell death (ICD). ICD is characterized by exposure of calreticulin and heat shock proteins (HSPs), secretion of ATP and release of high-mobility group box 1 (HMGB1). Proper activation of the immune system relies on the integration of these signals by dendritic cells (DCs). Studies on the crucial role of DCs, in the context of ICD, have been performed using mouse models or human in vitro-generated monocyte-derived DCs (moDCs), which do not fully recapitulate the in vivo situation. Here, we explore the effect of platinum-induced ICD on phenotype and function of human blood circulating DCs. Tumor cells were treated with OXP or CDDP and induction of ICD was investigated. We show that both platinum drugs triggered translocation of calreticulin and HSP70, as well as the release of ATP and HMGB1. Platinum treatment increased phagocytosis of tumor fragments by human blood DCs and enhanced phenotypic maturation of blood myeloid and plasmacytoid DCs. Moreover, upon interaction with platinum-treated tumor cells, CD1c(+) DCs efficiently stimulated allogeneic proliferation of T lymphocytes. Together, our observations indicate that platinum-treated tumor cells may exert an active stimulatory effect on human blood DCs. In particular, these data suggest that CD1c(+) DCs are critical mediators of immune responses induced by ICD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/2162402x.2016.1192739

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 105

Metadata

Authors
Di Blasio, S., Wortel, I. M. N., van Bladel, D. A. G., de Vries, L. E., Duiveman-de Boer, T., Worah, K., de Haas, N., Buschow, S. I., de Vries, I. J. M., Figdor, C. G., & Hato, S. V.
Venue
OncoImmunology
Published
2016-08-02
Volume
5
Issue
8
Pages
e1192739
ISSN
  • 2162-4011 (ISSN-L)
  • 2162-402X
OpenAlex
W2486961123
Cited by
105
References
13
FWCI
5.38
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human CD1c+ DCs are critical cellular mediators of immune responses induced by immunogenic cell death. https://app.cochat.ai/papers/10.1080/2162402x.2016.1192739
The paper
Di Blasio, S., Wortel, I. M. N., van Bladel, D. A. G., de Vries, L. E., Duiveman-de Boer, T., Worah, K., de Haas, N., Buschow, S. I., de Vries, I. J. M., Figdor, C. G., & Hato, S. V. (2016). Human CD1c+ DCs are critical cellular mediators of immune responses induced by immunogenic cell death. OncoImmunology. https://doi.org/10.1080/2162402x.2016.1192739

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.